| |
Latest 10 SEC filings (by transaction date) for PCSA within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Feb 8/24 | Feb 7/24 | Young David | Direct Ownership | Common Stock | P - Open market or private purchase | 21,000 | $2.45 |
Feb 7/24 | Feb 6/24 | Young David | Direct Ownership | Common Stock | P - Open market or private purchase | 20,000 | $2.53 |
Feb 1/24 | Feb 1/24 | Lin Patrick | Direct Ownership | Common Stock | P - Open market or private purchase | 1,500 | $2.40 |
Feb 1/24 | Jan 31/24 | Lin Patrick | Direct Ownership | Common Stock | P - Open market or private purchase | 2,500 | $2.37 |
Jan 31/24 | Jan 30/24 | Ng George K | Indirect Ownership | Common Stock | P - Open market or private purchase | 10,000 | $2.70 |
Jan 31/24 | Jan 30/24 | Yorke Justin W | Indirect Ownership | Common Stock | P - Open market or private purchase | 8,000 | $2.69 |
Nov 28/23 | Nov 21/23 | Yorke Justin W | Indirect Ownership | Common Stock | J - Other transaction | -55,267 | |
Oct 23/23 | Oct 12/23 | Yorke Justin W | Direct Ownership | Common Stock | A - Grant, award or other under Rule 16b-3(d) | 6,000 | $0.300 |
Oct 12/23 | Oct 12/23 | Guy Wendy | Direct Ownership | Common Stock | A - Grant, award or other under Rule 16b-3(d) | 14,771 | $0.340 |
Oct 12/23 | Oct 12/23 | Ng George K | Direct Ownership | Common Stock | A - Grant, award or other under Rule 16b-3(d) | 100,000 | $0.250 |
Sign up or login above to see all SEC filings within the past 6 months. |
Latest 10 SEC filings (by filing date) for PCSA within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Feb 8/24 | Feb 7/24 | Young David | Direct Ownership | Common Stock | P - Open market or private purchase | 21,000 | $2.45 |
Feb 7/24 | Feb 6/24 | Young David | Direct Ownership | Common Stock | P - Open market or private purchase | 20,000 | $2.53 |
Feb 1/24 | Feb 1/24 | Lin Patrick | Direct Ownership | Common Stock | P - Open market or private purchase | 1,500 | $2.40 |
Feb 1/24 | Jan 31/24 | Lin Patrick | Direct Ownership | Common Stock | P - Open market or private purchase | 2,500 | $2.37 |
Jan 31/24 | Jan 30/24 | Ng George K | Indirect Ownership | Common Stock | P - Open market or private purchase | 10,000 | $2.70 |
Jan 31/24 | Jan 30/24 | Yorke Justin W | Indirect Ownership | Common Stock | P - Open market or private purchase | 8,000 | $2.69 |
Nov 28/23 | Nov 21/23 | Yorke Justin W | Indirect Ownership | Common Stock | J - Other transaction | -55,267 | |
Oct 23/23 | Oct 12/23 | Yorke Justin W | Direct Ownership | Common Stock | A - Grant, award or other under Rule 16b-3(d) | 6,000 | $0.300 |
Oct 12/23 | Oct 12/23 | Guy Wendy | Direct Ownership | Common Stock | A - Grant, award or other under Rule 16b-3(d) | 14,771 | $0.340 |
Oct 12/23 | Oct 12/23 | Ng George K | Direct Ownership | Common Stock | A - Grant, award or other under Rule 16b-3(d) | 100,000 | $0.250 |
Sign up or login above to see all SEC filings within the past 6 months. |
Sign up or login above to see the past 6 months of filings sorted by insider. . |
Competitors with Recent Insider Filings |
Eyepoint Pharmaceuticals (OQ:EYPT) |
AbbVie (N:ABBV) |
Merck & Co (N:MRK) |